Swiftpharma
The computed 12-month bankruptcy probability of Swiftpharma is 1.6% (moderate). The 2025 annual accounts show equity of €835k and a net result of €-1.75M. Equity is growing by ~46.4% per year across the filed fiscal years. Its solvency ranks better than 29% of 322 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €835k |
| Net result | €-1.75M |
| Staff (FTE) | 12.3 |
| Better than sector | 29% |
Fragile profile, watch profitability in particular.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 17.0% | 35.1% | |
| Net result | €-1.75M | €44k | |
| Equity | €835k | €275k | |
| Gross operating margin | €-22k | €238k | |
| Staff costs | €1.19M | €171k |
| Fiscal year | 2025 |
|---|---|
| Revenue | - |
| EBITDA | €-1.23M |
| Net profit | €-1.75M |
| Cash flow | €-1.31M |
| Staff costs | €1.19M |
| Income taxes | €998 |
| Dividends | - |
| Total assets | €4.90M |
| Equity | €835k |
| Debt | €4.06M |
| of which ≤ 1y | €543k |
| of which > 1y | €3.52M |
| Working capital | €175k |
| Employees (FTE) | 12.3 |
| 2025 | |
|---|---|
| Current ratio | 1.32 |
| Quick ratio | 1.32 |
| Working capital ratio | 3.6% |
| Solvency | 17.0% |
| Debt / equity | 4.87 |
| Long-term debt ratio | 4.22 |
| Interest coverage | -14.13 |
| Gross margin | - |
| Net margin | - |
| ROA | -35.7% |
| ROE | -209.7% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €4.90M |
| Fixed assets | 21/28 | €4.18M |
| Intangible fixed assets | 21 | €2.02M |
| Tangible fixed assets | 22/27 | €2.13M |
| Financial fixed assets | 28 | €30k |
| Current assets | 29/58 | €718k |
| Amounts receivable within one year | 40/41 | €255k |
| Cash & bank | 54/58 | €434k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €4.90M |
| Equity | 10/15 | €835k |
| Contributions / capital | 10/11 | €4.41M |
| Reserves | 13 | €57k |
| Accumulated profits (losses) | 14 | €-3.63M |
| Amounts payable | 17/49 | €4.06M |
| Amounts payable after one year | 17 | €3.52M |
| Amounts payable within one year | 42/48 | €543k |
| Trade debts payable within one year | 44 | €372k |
| Income statement | ||
| Gross operating margin | 9900 | €-22k |
| Operating result | 9901 | €-1.67M |
| Financial income | 75 | €4k |
| Financial charges | 65 | €87k |
| Result before taxes | 9903 | €-1.75M |
| Income taxes | 67/77 | €998 |
| Net result for the period | 9904 | €-1.75M |
| Result to be appropriated | 9905 | €-1.75M |
-
HofMan BVLegal entityDirector· perm. rep.: Jeroen HofenkState Gazette act 25005104 (10-01-2025)Current01-12-2024 → present
-
ASTERION RESEARCH & DEVELOPMENTLegal entityDirector· perm. rep.: HOFENK JeroenState Gazette act 24432548 (01-10-2024)Current27-09-2024 → present
-
JVHealthLegal entityDirector· perm. rep.: VAN HAVERMAET JohanState Gazette act 24432548 (01-10-2024)Current27-09-2024 → present
-
Current27-09-2024 → present
Former directors (3)
-
Former08-08-2025 → 01-10-2025
2 events
- 01-10-2025 Resigned· Director
- 08-08-2025 Appointed· Director
-
JVHealthLegal entityDirector· perm. rep.: Johan Van HavermaetState Gazette act 25101276 (08-08-2025)Former- → 08-08-2025
-
Former- → 02-10-2023
2 events
- 02-10-2023 Resigned· Manager
- 23-08-2023 Resigned· Permanent representative
| NACE primary | Wholesale trade(46460) |
| Legal form | Private limited company(610) |
| Incorporation | 04-02-2022 |
| Status | Active |
| Postal code | 3600 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71303B1298/00W004 | Flanders | 2.3 ha | 1 · 1,622 m² | 18.3 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
03-12-2025 Registered office moved from Gent to Genk
- Karel van de Woestijnestraat 6, 9000 Gent → Thor Park 8027, 3600 Genk
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Genk",
"region": "Vlaams Gewest",
"street": "Thor Park",
"country": "BE",
"postcode": "3600",
"box_number": "0215",
"street_number": "8027"
},
"old_address": {
"city": "Gent",
"region": "Vlaams Gewest",
"street": "Karel van de Woestijnestraat",
"country": "BE",
"postcode": "9000",
"box_number": null,
"street_number": "6"
},
"effective_date": "2025-10-21",
"evidence_quote": "De RvB bespreekt het voorstel om het adres van de maatschappelijke zetel van de Vennootschap te verplaatsen van Karel van de Woestijnestraat 6, 9000 Gent naar Thor Park 8027, bus 0215, 3600 Genk."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0781.598.284",
"name_full": "SWIFTPHARMA",
"legal_form": "BV"
}
}08-10-2025 Bart Goddyn resigns as director
- Bart Goddyn, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Bart Goddyn",
"address": null,
"birth_date": null
},
"effective_date": "2025-10-01",
"evidence_quote": "De raad van bestuur heeft op 7 september 2025 kennis genomen van het vrijwillig ontslag van de Heer Bart Goddyn als bestuurder van de Vennootschap met ingang vanaf 1 oktober 2025."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0781.598.284",
"name_full": "SWIFTPHARMA",
"legal_form": "BV"
}
}08-08-2025 1 director appointed, 1 resigning
- Bart Goddyn, Bestuurder
- Johan Van Havermaet, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Johan Van Havermaet",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0667843119",
"name": "JV Health BV",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "JV Health BV (0667.843.119), vast vertegenwoordigd door Johan Van Havermaet, heeft zijn ontslag als bestuurder meegedeeld aan de raad van bestuur van de vennootschap op 26 maart 2025."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Bart Goddyn",
"address": null,
"birth_date": null
},
"evidence_quote": "Na beraadslaging besluit de algemene vergadering Bart Goddyn definitief tot bestuurder te benoemen voor onbepaalde duur."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0781.598.284",
"name_full": "SWIFTPHARMA",
"legal_form": "BV"
}
}10-01-2025 1 director appointed, 1 resigning
- Jeroen Hofenk, Bestuurder
- Asterion Research & Development BV, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Asterion Research \u0026 Development BV",
"address": null,
"birth_date": null
},
"effective_date": "2024-12-01",
"evidence_quote": "De bijzondere algemene vergadering heeft akte genomen van het ontslag van Asterion Research \u0026 Development BV (KB\u041E 0682.704.608) als bestuurder van de Vennootschap met ingang vanaf 1 december 2024."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jeroen Hofenk",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "HofMan BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-12-01",
"evidence_quote": "De bijzondere algemene vergadering heeft met eenparigheid van stemmen besloten HofMan BV, met zetel te 9000 Gent, Karel van de Woestijnestraat 6, te benoemen tot bestuurder van de Vennootschap met ingang vanaf 1 december 2024, met als vaste vertegenwoordiger de Heer Jeroen Hofenk (geboren op 15 sept"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0781.598.284",
"name_full": "SWIFTPHARMA",
"legal_form": "BV"
}
}01-10-2024 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2024-09-27",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0781.598.284",
"name_full": "SWIFTPHARMA",
"legal_form": "BV"
},
"signature_regime": "joint_by_class",
"special_mandates": [
{
"quote": "De vergadering verleent bijzondere volmacht aan ... de besloten vennootschap \u201CAccratio\u201D, met zetel te 2800 Mechelen, Blarenberglaan 4, BTW-nummer BE0821.971.367, Ondernemingsnummer (RPR Antwerpen, afdeling Mechelen) 0821.971.367 en al haar aangestelden, zowel wat betreft (i) en (ii) allen individueel bevoegd, evenals aan hun bedienden, aangestelden en lasthebbers, met mogelijkheid tot indeplaatsstelling, teneinde de vervulling van de formaliteiten bij een ondernemingsloket met het oog op de inschrijving/aanpassing van de gegevens in de Kruispuntbank van Ondernemingen, en, desgevallend, bij de Administratie van de Belasting over de Toegevoegde Waarde, te verzekeren.",
"holder_kbo": "0821971367",
"holder_name": "Accratio",
"scope_categories": [
"KBO",
"filing",
"tax"
],
"with_substitution": true
},
{
"quote": "De vergadering verleent bijzondere volmacht aan (i) Victor Burki, en ieder ander advocaat of medewerker van het advocatenkantoor Agio Legal, die te dien einde allen woonstkeuze doen te 2180 Antwerpen, Bist 47, ... met mogelijkheid tot indeplaatsstelling, teneinde de vervulling van de formaliteiten bij een ondernemingsloket met het oog op de inschrijving/aanpassing van de gegevens in de Kruispuntbank van Ondernemingen",
"holder_kbo": null,
"holder_name": "Agio Legal",
"scope_categories": [
"KBO",
"filing"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}01-02-2024 2 resigning
- BV CHRISTIAN DEPREZ CONSULTING, Bestuurder
- Christian Deprez, Vaste vertegenwoordiger
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "BV CHRISTIAN DEPREZ CONSULTING",
"address": null,
"birth_date": null
},
"evidence_quote": "Bij de neerlegging van het ontslag van een bestuurder op 20/09/2023 werd BV CHRISTIAN DEPREZ CONSULTING ontslagen als bestuurder."
},
{
"kind": "director_out",
"role": "vaste_vertegenwoordiger",
"person": {
"rrn": null,
"name": "Christian Deprez",
"address": null,
"birth_date": null
},
"effective_date": "2023-08-23",
"evidence_quote": "Daarnaast dient ook opgenomen te worden dat dhr. Christian Deprez ontslagen wordt als vaste vertegenwoordiger en dit vanaf 23/08/2023."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0781.598.284",
"name_full": "SWIFTPHARMA",
"legal_form": "BV"
}
}02-10-2023 Christian Deprez resigns as manager
- Christian Deprez, Zaakvoerder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Christian Deprez",
"address": null,
"birth_date": null
},
"evidence_quote": "Tijdens de Bijzondere Algemene Vergadering van 23-08*2023, waar alle zaakvoerders van SwiftPharma aanwezig waren, werd belist en aanvaard dat de heer Christian Deprez (CD Consulting) ontslag neemt als zaakvoerder in de vennootschap."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0781.598.284",
"name_full": "SWIFTPHARMA",
"legal_form": "BV"
}
}12-06-2023 Registered office moved from Wondelgem to Gent
- Industrieweg 18, 9032 Wondelgem → Karel van de Woestijnestraat 6, 9000 Gent
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Gent",
"region": null,
"street": "Karel van de Woestijnestraat",
"country": "BE",
"postcode": "9000",
"box_number": null,
"street_number": "6"
},
"old_address": {
"city": "Wondelgem",
"region": null,
"street": "Industrieweg",
"country": "BE",
"postcode": "9032",
"box_number": "4",
"street_number": "18"
},
"effective_date": "2023-05-01",
"evidence_quote": "Onderwerp akte: ZETELVERPLAATSING BIJ BESLISSING BESTUURDERS 01/05/2023\nBij gewone beslissing van de bestuurders wordt er besloten om de zetel te verplaatsen\nvanaf 01/05/2023:\n- van: Industrieweg 18 bus 4 te 9032 Wondelgem\n- naar: Karel van de Woestijnestraat 6 te 9000 Gent"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0781.598.284",
"name_full": "SWIFTPHARMA",
"legal_form": "BV"
}
}05-10-2022 Registered office moved from Mechelen to Wondelgem
- Schuttersvest 53, 2800 Mechelen → Industrieweg 18, 9032 Wondelgem
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Wondelgem",
"region": null,
"street": "Industrieweg",
"country": "BE",
"postcode": "9032",
"box_number": "4",
"street_number": "18"
},
"old_address": {
"city": "Mechelen",
"region": null,
"street": "Schuttersvest",
"country": "BE",
"postcode": "2800",
"box_number": null,
"street_number": "53"
},
"effective_date": "2022-09-06",
"evidence_quote": "Bij gewone beslissing van de bestuurders wordt er besloten om de maatschappelijke zetel te verplaatsen vanaf 06/09/2022: - van: Schuttersvest 53 te 2800 Mechelen - naar: Industrieweg 18 bus 4 te 9032 Wondelgem"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0781.598.284",
"name_full": "SWIFTPHARMA",
"legal_form": "BV"
}
}08-02-2022 Incorporation of a new BV
Technical details
{
"kind": "oprichting",
"seat": "Schuttersvest 53, 2800 Mechelen",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": "0682.704.608",
"name": "Asterion Research \u0026 Development"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "A",
"partner_role": null,
"holder_org_kbo": "0682.704.608",
"holder_org_name": "Asterion Research \u0026 Development",
"contribution_type": "cash",
"amount_paid_in_eur": 2500,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 1,
"amount_subscribed_eur": 2500,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1965-11-20",
"name": "Van Havermaet, Johan Roger Paul Maria",
"niss": null,
"address": "7880 Vloesberg, Brique 7 D"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 2500,
"holder_person_name": "Van Havermaet, Johan Roger Paul Maria",
"is_subscriber_only": true,
"n_shares_subscribed": 1,
"amount_subscribed_eur": 2500,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1952-02-29",
"name": "Deprez, Christian Marie Joseph",
"niss": null,
"address": "2580 Putte, Poortmanshof 8 bus 0401"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 2500,
"holder_person_name": "Deprez, Christian Marie Joseph",
"is_subscriber_only": true,
"n_shares_subscribed": 1,
"amount_subscribed_eur": 2500,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 2500,
"subject_company": {
"kbo": "0781.598.284",
"name_full": "Swiftpharma",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2022-02-03",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Swiftpharma |